WuXi AppTec Receives Frost & Sullivan's Global Company of the Year Recognition in CRDMO for Tenth Consecutive Year
SHANGHAI, Oct. 20, 2026 /PRNewswire/ -- WuXi AppTec, a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), has received Frost & Sullivan's 2026 Global Company of the Year Recognition in the CRDMO industry for the tenth consecutive year. Frost & Sullivan highlighted WuXi AppTec's integrated CRDMO model, which enables the company to support customers across the full drug development lifecycle, from early discovery through commercial manufacturing.
The firm noted WuXi AppTec's global capacity, operational consistency, and ability to adapt to…
Read the full report on Pr Newswire Apac
Story file
- Section
- Lifestyle
- First reported by
- Pr Newswire Apac
- Reporter
- cision pr newswire
- Published
- Tuesday, 20 October 2026, 5:30 am IST
- Coverage
- One outlet so far
How this page works. The Headline Update lists this report from Pr Newswire Apac with a short summary and a link to the original. The original reporting belongs to the publisher. Spotted an error in our summary? Tell our corrections desk.
